Sanjay Koul

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Warren Fiskus, Yongchao Wang, Arun Sreekumar et al. · Blood · 2009 · 355 citations · Full text

Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable <i>MET</i> Gene Mutations

Xuewen Liu, Yuxia Jia, Mark Stoopler et al. · Journal of Clinical Oncology · 2015 · 336 citations

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.

Gopeshwar Narayan, Hugo Arias‐Pulido, Sanjay Koul et al. · Molecular Cancer · 2003 · 221 citations · Full text

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells

Yongchao Wang, Warren Fiskus, Daniel G. Chong et al. · Blood · 2009 · 177 citations · Full text

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.

Sanjay Koul, James M. McKiernan, Gopeshwar Narayan et al. · Molecular Cancer · 2004 · 135 citations · Full text